PRKCH and chronic myelogenous leukemia, BCR-ABL1 positive: Sinnakannu et al. reported that high SRSF1 expression in chronic myeloid leukemia was associated with imatinib resistance, which was mediated by the SRSF1/PRKCH/PLCH1 axis [24].